SCHEMBL7569014

SCHEMBL7569014

Cc1cc(NC(=O)Cc2cc(C(=N)N)ccc2O)ccc1-n1cnc2ccccc21

nearest known ligand 0.48

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.48
KMT2A Q03164 1/20 0.48
F10 P00742 14/20 0.46
F9 P00740 10/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
HTT P42858 1/20 0.46
F2 P00734 5/20 0.45
PRSS1 P07477 4/20 0.45
LMNA P02545 3/20 0.42
TP53 P04637 1/20 0.42
KLK5 Q9Y337 1/20 0.41
ALDH1A1 P00352 1/20 0.41
HPGD P15428 1/20 0.41
PRSS2 P07478 1/20 0.40
PRSS3 P35030 1/20 0.40
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL6939888 0.99 MEN1 (0.48) MEN1KMT2AF10F9SMN1; SMN2
SCHEMBL7071377 0.84 KLK5 (0.41) MEN1KMT2AF10SMN1; SMN2HTT
Hydrochloric Acid SCHEMBL6943397 0.84 KLK5 (0.41) MEN1KMT2AF10SMN1; SMN2HTT
SCHEMBL7562464 0.82 KLK5 (0.42) MEN1KMT2AF10SMN1; SMN2HTT
SCHEMBL7562571 0.82 KLK5 (0.39) MEN1KMT2AF10SMN1; SMN2HTT
SCHEMBL6941666 0.81 F10 (0.39) MEN1KMT2AF10F2PRSS1
Hydrochloric Acid SCHEMBL7566109 0.81 KLK5 (0.39) MEN1KMT2AF10SMN1; SMN2HTT
Hydrochloric Acid SCHEMBL7561132 0.81 F10 (0.38) MEN1KMT2AF10F2PRSS1
SCHEMBL7561800 0.80 F10 (0.38) F10SMN1; SMN2HTTF2PRSS1
Hydrochloric Acid SCHEMBL6939389 0.79 F10 (0.37) F10SMN1; SMN2HTTF2PRSS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020183519-A1 Antithrombotic carboxylic acid amides BOEHRINGER INGELHEIM PHARMA KG (DE) 2002-12-05 US claimed
US-20020183519-A1 Antithrombotic carboxylic acid amides BOEHRINGER INGELHEIM PHARMA KG (DE) 2002-12-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020183519-A1 Antithrombotic carboxylic acid amides SERPINC1, TFPI, F2 MEN1 2312/4885KMT2A 332/4885F10 33/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.